Oswal Overseas (531065)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price is close to book value at ₹5.14 versus ₹4.85, so downside may be partially supported if assets are real.
• Piotroski F-Score of 5/9 suggests a middling financial position, not a completely failed one.
• Profit growth of 58.44% hints at year-on-year base effects or some cost improvement, though earnings are still negative.
• Latest quarter net loss of ₹-2 crore is relatively small against the ₹166 crore market cap, leaving room for an operational turnaround.
• Small market cap and commodity sector exposure make it a possible restructuring/corporate-action candidate.

Concerns

• Sales collapsed by 91.71%, and latest quarterly revenue is only ₹1 crore, indicating near-total business decline.
• ROE of -134.19% and ROCE of -33.50% are deeply negative, meaning shareholder equity is being destroyed.
• P/E is meaningless because earnings are negative; the latest quarter still shows a net loss of ₹-2 crore.
• No dividend, no promoter holding disclosure, and the 52-week range inconsistent with the current price make valuation and oversight unreliable.

AI Analysis

Let me start with what I can see. This is a sugar company, a commodity business with little pricing power unless it has scale or cost advantages. Oswal Overseas shows none of that in these numbers. Sales growth is minus 91.71%, the latest quarter revenue is just ₹1 crore, and net profit is minus ₹2 crore. A company losing money at this level cannot be valued on a P/E ratio; the reported P/E of zero only tells you earnings are not there. Return on equity is minus 134.19% and ROCE is minus 33.50%. Every rupee of book value is earning a deeply negative return. Book value is ₹4.85 and the stock trades at ₹5.14, roughly 1.06 times book. That appears cheap only if the assets are worth what the balance sheet says and can earn a return. They are not currently earning anything. In Graham's language, you want a margin of safety; here you would be paying slightly above book for a loss-making, collapsing business. The stated 52-week range of ₹45.75 to ₹143.00 is inconsistent with the current price, so historical price comparisons cannot be trusted without adjustment. Promoter holding is not disclosed, and the dividend yield is zero, so the investor gets no cash while waiting. The Piotroski score of 5 out of 9 is mediocre, not a strong signal. The reported profit growth of 58.44% means little when the base was likely negative or distorted. This is not a franchise or a compounder. At best, it is a potential turnaround or asset situation, but only if the true value of the assets and the debt structure are made clear. I would pass until I see sales stability, positive earnings, and a clean balance sheet.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer